• June 16-19, 2025
  • Boston Convention & Exhibition Center

Brick-by-Brick: Building a Biotech from Foundation Up with Venture Investor Company Formation

Loading

Brick-by-Brick: Building a Biotech from Foundation Up with Venture Investor Company Formation

Tuesday, June 04, 2024
Breakout Session
Business Development and Finance
26B
Startups and VCs have a symbiotic relationship that can sometimes experience many ups and downs. What happens when startups work with venture investors from the beginning to create a new company around a technology or asset, and how difficult is it for these companies to become independent following their launch out of stealth? With deep benches of scientists, shared office infrastructure, incubators, and extensive industry experience, many VC firms have a breadth of assets that science-driven startups need. Hear from two high profile venture firms and the leaders of two companies they helped form about the pros, challenges and pitfalls of company formation efforts led by VCs.
Speakers
Allison DeAngelis
Reporter
STAT News
Speakers
Ann Lee-Karlon, PhD
Chief Executive Officer and President
EpiBiologics
Amy Liu
Investor
Mubadala Capital
Sanjay Mistry, PhD
Vice President
Johnson & Johnson Innovation
Mitchell Mutz, Ph.D
Entrepreneur Partner
Vivo Capital
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS